144 Infos zu Dirk Beher

40 Aktuelle Nachrichten

A CURE for Alzheimer's is moving closer with trials of breakthrough drugs that could halt the crippling effects of the disease.

Geleitet wird das Unternehmen von Dirk Beher, Christoph Wiessner und Frank Armstrong. Publiziert: , 10:40 Dieser Artikel wurde automatisch aus unserem alten Redaktionssystem auf unsere ...

LAUSANNE, Switzerland, October 6, PRNewswire/ -- Asceneuron SA, an emerging leader in the development of innovative small molecules for...

Seasoned pharma & biotech executive joins the Board of mid-stage clinical company Lausanne, SWITZERLAND and CAMBRIDGE, Massachusetts, May 20,

1  Bilder zu Dirk Beher

11 Profile in Sozialen Netzwerken

Profile der Personen mit dem Namen Dirk Beher auf Facebook anzeigen Tritt Facebook bei, um dich mit Dirk Beher und anderen Nutzern, die du vielleicht ...

6 Hobbys & Interessen

Lausanne, SWITZERLAND and CAMBRIDGE, Massachusetts, May 20, PRNewswire/ -- Asceneuron, an emerging leader in the development of orally bioav...

Dirk Beher patents. Recent bibliographic sampling of Dirk Beher patents listed/ published in the public domain by the USPTO (USPTO Patent Application #,Title):  ...

› asc...

... Hellen Kim, Andrew Madin, Joanne C. Hannam, A. Thomas Look, Nancy Kohl, Giulio Draetta, Timothy Harrison, Julie A. Kerby, Mark S. Shearman, Dirk Beher. › cell-chemical-biology › ppt

1 Firmen-Beteiligungen

› list

3 Business-Profile

MERCK SHARP & DOHME LTD.

Kollegen. At Asceneuron, Dirk Beher has 1 colleague who can be contacted.. Branchenkollegen. In der Biotechnologie Branche hat Dirk Beher Kollegen bei Unternehmen in 42 Ländern Veränderungen bei Führungskräften sind in den letzten 12 Monaten registriert worden.

· Das Organigramm von Asceneuron zeigt 17 Führungskräfte, einschließlich einschließlich Dirk Beher, Manfred Schneider, Ruhi Ahmed und Ryan Schubert

8 Bücher zum Namen

Dirk Beher on Inventory of Tau Modifications Hints at Undiscovered Functions. COMMENT This manuscript by Morris and colleagues describes the systematic ...

... aen alle söne Gheloobigen het Broodt te eten / maer oock den Dirk - beher te dzincken . ten tweeden / foo ontkennen wp / dat den gheheelen Jesus in het b .

1 Wissenschaftliche Publikationen

von S Weggen · · Zitiert von: 169 — Sascha Weggen &; Dirk Beher. Alzheimer's Research & Therapy volume 4, Article number: 9 (2012) Cite this article. 11k Accesses. 98 Citations. › ...

9 Meinungen & Artikel

› status

· Dirk Beher, CEO & Founder, was interviewed by Mike Ward (Scrip Pharma Intelligence) at the Biotech Showcase in San Francisco last week.

... MD, PhD—Georgetown University, Allan Levey, MD, PhD—Emory University, Sharon Rosenzweig-Lipson, PhD—AgeneBio,, Dirk Beher, PhD—Asceneuron, Mari DeMarco, ... › event

— Profile · Dirk Beher, Ph.D. · Contact Information · Professional Information · Education · Financial Disclosure · Comments. › dirk-b...

56 Webfunde aus dem Netz

The invention provides methods of identifying compounds suitable for treating Alzheimer's disease and related conditions by means of modulation of...

Applicant, Dirk Beher, Merck Sharp & Dohme, Jonathan David Wrigley. Export Citation, BiBTeX, EndNote, RefMan. Classifications (12), Legal ...

vor 1 Tag · Dirk Beher, Chief Executive Officer and a Co-Founder of Asceneuron, commented: "This Phase I clinical study targeting the root cause of ...

› ...

Dirk Beher (1) Gemma Beher (1) Jutta Beher (1) Walter Beher (1) Andreas Beher (1) Emilie Beher (1) Frank Beher (1) George Beher (1) Christian Beher (1) › details › Beher

Die Gründer von Asceneuron sind Dirk Beher (Chief Scientific Officer), Christoph Wiessner (Leiter Discovery) sowie Frank Armstrong ...

› ...

› dirk-beher-...

› dirk...

... David Beher, Dirk Quddus, Abdul. Assignee: MERCK SHARP & DOHME LIMITED ... Inventor： Beher, Dirk Wrigley, Jonathon. Assignee: Beher, Dirk ...

Die in Lausanne ansässige Asceneuron wurde von Dirk Beher (CEO) und Christoph Wiessner (COO) aus Merck-Serono ausgegründet. Der deutsche Pharmakonzern unterstützte das Vorhaben mit dem im Zuge der Schließung des Serono-Hauptquartiers in Genf …

Dirk Beher, chief executive officer and a founder of Asceneuron, commented: "PSP is a rare neurological condition for which there is currently no treatment available. ASN is an orally bioavailable molecule that has the potential of treating the root cause of the neurodegeneration. The granting of Orphan Drug Designation for ASN by the FDA is an important milestone for the team and ...

Dirk Beher, PhD. Asceneuron. Dirk Beher is the Chief Executive Officer, Founder and Member of the Board of Directors of Asceneuron. Since the creation ...

vor 5 Stunden · Dirk Beher, Chief Executive Officer and a Co-Founder of Asceneuron, commented: “This Phase I clinical study targeting the root cause of ...

Bruno Permanne, Astrid Sand, Solenne Ousson, Maud Nény, Jennifer Hantson, Ryan Schubert, Christoph Wiessner, Anna Quattropani, Dirk Beher. › container

Dirk Beher, Switzerland: O-GlcNAcase inhibitors for tauopathies – translation of a research finding to a clinical candidate molecule. › crbst_11

jobs with Asceneuron to view and apply for now with BioSpace

2005 Nov;14(11): doi: Authors. Dirk Beher , ...

vor 6 Tagen — Asceneuron was founded in and was founded by Dirk Beher. Asceneuron has a total of 140 patents. Related Topics. › ...

Dirk Beher, b ... aDepartment of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, The Neuroscience Elsevier Ltd. All rights reserved.